Cladribine tablets in people with relapsing multiple sclerosis: A real-world multicentric study from southeast European MS centers

A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis

Gavin Giovannoni, Stuart D. Cook, Kottil Rammohan et al. · New England Journal of Medicine · 2010 · 1K citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +16

Safety and efficacy of cladribine tablets in patients with relapsing–remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study

Gavin Giovannoni, Per Soelberg Sørensen, Stuart D. Cook et al. · Multiple Sclerosis Journal · 2017 · 333 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +10

Relapses in multiple sclerosis are age- and time-dependent

Helen Tremlett, Yinshan Zhao, Joyce Pauline Joseph et al. · Journal of Neurology Neurosurgery & Psychiatry · 2008 · 273 citations

Medicine, Biostatistics, Neurology +13

Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis

Gavin Giovannoni, Stuart D. Cook, Kottil Rammohan et al. · The Lancet Neurology · 2011 · 246 citations

Medicine, Neurology, Pharmacotherapy +10

No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine

Julia Pakpoor, Giulio Disanto, Daniel R. Altmann et al. · Neurology Neuroimmunology & Neuroinflammation · 2015 · 130 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15